Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy

Epilepsia

Volumn 37, Issue 2, 1996, Pages 181-187

  Salinsky, M C ^a,b   Oken, B S ^a   Binder, L M ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antiepileptic drugs; Drowsiness; Electroencephalography; Epilepsy

Indexed keywords

ANTICOAGULANT AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DROWSINESS; ELECTROENCEPHALOGRAM; EPILEPSY; FATIGUE; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF REPORT; SOMNOLENCE; TASK PERFORMANCE; WAKEFULNESS;

ADULT; AGE FACTORS; ANTICONVULSANTS; CARBAMAZEPINE; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; MIDDLE AGED; PHENOBARBITAL; PHENYTOIN; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; SLEEP STAGES; VALPROIC ACID; WAKEFULNESS;

EID: 0030042861     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00010.x     Document Type: Article

References (41)

1. Collaborative Group for the Study of Epilepsy. Adverse reactions to antiepileptic drugs: a multicenter survey of clinical practice. Epilepsia 1986;27:323-30.
2. Mattson RH. Selection of antiepileptic drug therapy. In: Levy R, Mattson RH, Meldrum B, Penry JK, eds. Antiepileptic Drugs, 3rd ed. New York: Raven Press, 1989:103-15.
3. Heller AJ, Chesterman P, Elwes RDC, et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomized comparative monotherapy trial. J Neurol Neurosurg Psychiatry 1995;58: 44-50.
4. Mattson RH, Cramer JA, Collins JF. Valproate for treatment of partial and secondarily generalized tonic-clonic seizures in adults: a comparison with carbamazepine. N Engl J Med 1992;327:765-71.
5. Ramsay R, Wilder BJ, Berger J, Bruni J. A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults. Neurology 1983;33:904-10.
6. Shorvon SD, Reynolds EH. Reduction in polypharmacy for epilepsy. Br Med J 1979;2:1023-5.
7. Theodore WH, Porter RJ. Removal of sedative-hypnotic drugs from the regimens of patients with intractable epilepsy. Ann Neurol 1983;13:320-4.
8. Simon CW, Emmons WH. EEG, consciousness, and sleep. Science 1956;19:1066-9.
9. Morrell L. EEG frequency and reaction time: a sequential analysis. Neuropsychologia 1966;4:41-8.
10. Valley V, Broughlon R. The physiological (EEG) nature of drowsiness and its relation to performance deficits in narcoleptics. Electroencephalogr Clin Neurophysiol 1983;55:243-51.
11. Seidenberg M, Taylor MA, Haltiner A. Personality and self-report of cognitive functioning. Arch Clin Neuropsychol 1994;9:353-61.
12. Manni R, Ratti E, Perucca E, Galimberti CA, Tartara A. A multiparametric investigation of daytime sleepiness and psychomotor functions in epileptic patients treated with phenobarbital and sodium valproate: a comparative controlled study. Electroencephalogr Clin Neurophysiol 1993;86:322-8.
13. Mitler M, Gujavarty S, Browman C. Maintenance of Wakefulness Test: a polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol 1982;53:658-61.
14. Hoddes E, Zarcone V, Smythe H, et al. Quantification of sleepiness: a new approach. Psychophysiology 1973;10:431-6.
15. Wechsler D. WAIS-R manual. New York: Psychological Corporation, 1981.
16. Lorr M, McNair DM, Droppleman DF. Manual: profile of mood states. San Diego, CA: Educational and Industrial Testing Service, 1971.
17. Santamaria J, Chiappa K. The EEG of drowsiness. New York: Demos, 1989.
18. SAS Release 6.04. SAS Institute, Cary, NC, 1990.
19. Trimble MR. Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia 1987;28(suppl 3):s37-45.
20. Dodrill CB. Effects of antiepileptic drugs on abilities. J Clin Psychiatry 1988;49:31-4.
21. Smith DB. Cognitive effects of antiepileptic drugs. In: Smith DB, Treiman D, Trimble M, eds. Neurobehavioral problems in Epilepsy. New York: Raven Press, 1991:197-212.
22. Meador KJ, Loring DW. Cognitive effects of antiepileptic drugs. In: Devinsky O, ed. Epilepsy and behavior. New York: Wiley-Liss, 1991:151-70.
23. Dodrill CB. Diphenylhydantoin serum levels, toxicity and neuropsychological performance in patients with epilepsy. Epilepsia 1975;16:593-600.
24. Dodrill CB, Temkin N. Motor speed is a contaminating factor in evaluating the cognitive effects of phenytoin. Epilepsia 1989;30:453-7.
25. Meador KJ, Loring DW, Allen ME, et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991;41:1537-40.
26. Aldenkamp AP, Vermuelen J, Alpherts WCJ, Overweg J, VanParijs JAP, Verhoeff NPLG. Validity of computerized testing: patient dysfunction and complaints versus measured changes. In: Dodson W, Kinsbourne M, Hiltbrunner B, eds. The assessment of cognitive function in epilepsy. New York: Demos. 1991:51-68.
27. Hutt SJ, Jackson PM, Belsham A, Higgins G. Perceptual-motor behavior in relation to blood phenobarbitone level. Dev Med Child Neurol 1968;10:626-32.
28. Matthews CG, Harley JP. Cognitive and motor-sensory performances in toxic and nontoxic epileptic subjects. Neurology 1975;25:184-8.
29. Dodrill CB. When is computer assisted testing appropriate? In: Dodson W, Kinsbourne M, Hiltbrunner B, eds. The assessment of cognitive function in epilepsy. New York: Demos, 1991:23-34.
30. Dodrill CB, Arnett JL, Sommerville KW, Sussman NM. Effects of differing dosages of vigabatrin on cognitive abilities and quality of life in epilepsy. Epilepsia 1995;36:164-73.
31. Wilkinson RT. Sleep deprivation. In: Edholm OG, Bacharach AL, eds. The physiology of human survival. New York: Academic Press, 1965:399-430.
32. Kjellberg A. Sleep deprivation and some aspects of performance. Waking sleeping 1977;1:145-8.
33. Wilkus RJ, Dodrill CB, Troupin AS. Carbamazepine and the electroencephalogram in epileptics: a double blind study in comparison to phenytoin. Epilepsia 1978;19:283-91.
34. Besser R, Hornung K, Theisohn M, Rothacher G, Kramer G. EEG changes in patients during the introduction of carbamazepine. Electroencephalogr Clin Neurophysiol 1992; 83:19-23.
35. Herkes GK, Lagerlund TD, Sharbrough FW, Eadie MJ. Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients. J Clin Neurophysiol 1993;10:210-6.
36. Salinsky MC, Oken BS, Morehead L. Intraindividual analysis of antiepileptic drug effects on EEG background rhythms. Electroencephalogr Clin Neurophysiol 1994;90: 186-93.
37. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Washington DC: U.S. Government Printing Office, 1968.
38. Kubicki ST, Herrmann WM, Holler L. Critical comments on the rules of Rectschaffen and Kales concerning the visual evaluation of EEG sleep records. In: Herrmann WM, ed. Electroencephalography in drug research. Stuttgart: Gustav Fischer. 1982:387-403.
39. Frost JD, Hrachovy RA, Glaze DG, Rettig GM. Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance. J Clin Neurophysiol 1995;12:57-63.
40. Schmidt D, Haenel F. Therapeutic plasma levels of phenytoin, phenobarbitol, and carbamazepine: individual variation in relation to seizure frequency and type. Neurology 1984; 34:1252-5.
41. Cramer JA, Scheyer R, Hochholzer J, Mattson RH. Carbamazepine concentrations and adverse effects. Epilepsia 1991;32(suppl 3):14.